Oncternal Therapeutics

+$0.17 (+4.74%) As of 6:12 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCT and other ETFs, options, and stocks.

About ONCT

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Cirmtuzumab, TK216, and ROR1 CAR-T.

CEO
James B. Breitmeyer
Employees
14
Headquarters
San Diego, California
Founded
1997

ONCT Key Statistics

Market Cap
185.69M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
367.48K
High Today
$3.77
Low Today
$3.59
Open Price
$3.60
Volume
141.65K
52 Week High
$10.56
52 Week Low
$1.49

ONCT Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure